Helen Milton

No open positions remaining

Health Technology

Consumer Services

Profile

Helen Milton formerly worked at Keryx Biopharmaceuticals, Inc., as Vice President-Global Regulatory Affairs & Quality from 2014 to 2017, AMAG Pharmaceuticals, Inc., as Senior VP-Regulatory Affairs & Quality in 2020, Mallinckrodt Pharmaceuticals, as Senior VP-Regulatory Affairs & Pharmacovigilance from 2021 to 2022, and Viridian Therapeutics, Inc., as Senior Vice President-Regulatory Affairs from 2023 to 2024.
Dr. Milton received her undergraduate degree and doctorate degree from The University of Liverpool.

Former positions of Helen Milton

Companies	Position	End
VIRIDIAN THERAPEUTICS, INC.	General Counsel	02/01/2024
AMAG PHARMACEUTICALS, INC.	General Counsel	01/12/2020
KERYX BIOPHARMACEUTICALS	General Counsel	01/05/2017

See the detail of Helen Milton's experience

Training of Helen Milton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Helen Milton's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease	Health Technology
The University of Liverpool The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products	Health Technology